Tetrabenazine
NDC Package 52682-062-14

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Tetrabenazine is used to decrease the uncontrollable movements (chorea) caused by Huntington's disease. Marketed by Ingenus Pharmaceuticals Nj, Llc, this product is identified by NDC 52682-062 and is authorized under FDA application ANDA207682.

Identification & Billing

NDC Package Code
52682-062-14
Package Description
112 TABLET in 1 BOTTLE, PLASTIC
Product Code
52682-062
11-Digit Billing Format
52682006214

Clinical Specifications

Proprietary Name
Tetrabenazine
Dosage Form
-
Usage Information
Tetrabenazine is used to decrease the uncontrollable movements (chorea) caused by Huntington's disease. However, it is not a cure for the disease. Reducing the chorea will help you take part in more of your normal daily activities. This medication is thought to work by decreasing the amount of certain natural substances in the brain (monoamines such as dopamine, serotonin, and norepinephrine), which are involved with nerve and muscle function. Tetrabenazine belongs to a class of drugs called monoamine depletors.

Regulatory & Marketing

Labeler Name
Ingenus Pharmaceuticals Nj, Llc
FDA Application #
ANDA207682
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-01-2017
End Marketing Date
03-01-2017
Listing Expiration
03-01-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 52682-062-14 identifies a specific commercial package of 112 tablet in 1 bottle, plastic of Tetrabenazine, labeled by Ingenus Pharmaceuticals Nj, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ingenus Pharmaceuticals Nj, Llc on March 01, 2017. The current certification is valid through March 01, 2017.

What are the primary indications for this medication?

Tetrabenazine is used to decrease the uncontrollable movements (chorea) caused by Huntington's disease. However, it is not a cure for the disease. Reducing the chorea will help you take part in more of your normal daily activities. This medication is thought to work by decreasing the amount of certain natural substances in the brain (monoamines such as dopamine, serotonin, and norepinephrine), which are involved with nerve and muscle function. Tetrabenazine belongs to a class of drugs called monoamine depletors.

How is this Ingenus Pharmaceuticals Nj, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 52682006214. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
52682-062-14
11-Digit CMS (5-4-2)
52682-0062-14

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.